Mark S. Wilke, PhD Associate Patent Agent


Speaks:  English

Year of Call: 2012 - British Columbia

Primary phone: +1 604-891-2782

Fax: +1 604-683-3558

Email: mark.wilke@gowlingwlg.com

Download VCard


Primary office:  Vancouver




Mark S. Wilke, PhD

Mark Wilke is a Vancouver-based Gowling WLG associate and patent agent who advises on intellectual property law, with an emphasis on drafting and obtaining patents related to the life sciences.

His clients are typically companies, universities and inventors in Canada seeking to obtain patent protection in Canada or internationally, as well as associate firms outside of Canada seeking to obtain Canadian patent protection for their own clients.

Mark advises on all aspects of the patenting process, including patentability, drafting, prosecution, validity and infringement. He also represents clients in respect of various contractual matters involving intellectual property, such as confidentiality agreements, research and development agreements and assignments.

He is experienced with a diverse set of technologies, including biotechnology, immunology, gene/RNA therapies, pharmaceuticals, diagnostics, medical devices and bioremediation. Prior to his legal career, Mark completed a doctorate at the University of British Columbia, where he investigated the regulation of antibiotic resistance in pathogenic superbugs using X-ray crystallography and nuclear magnetic resonance. As such, his background is particularly advantageous for matters requiring a detailed understanding of the relationship between molecular structures and their biological functions. 

Outside of the office, Mark is an active member of his local home brewing community and has been brewing beer for over a decade. 

Mark is a registered patent agent in both Canada and the United States.

Career & Recognition

Filter timeline:
  • 2013

    • Career
      December2013
      Patent Agent, USA
    • Career
      September2013
      Patent Agent, Canada
    • Career
      April2013
      Trademark Agent, Canada
  • 2012

    • Qualifications (Year of Call/Admission, etc.)
      2012
      Year of Call, British Columbia
  • 2011

    • Education
      2011
      University of British Columbia, JD
  • 2008

    • Education
      2008
      University of British Columbia, PhD, Biochemistry
  • 2002

    • Education
      2002
      University of Guelph, B.Sc., Biochemistry

Memberships

  • Canadian Bar Association
  • Intellectual Property Institute of Canada (IPIC)

Wilke MS, Prohibiting Medical Method Patents: A Criticism of the Status Quo, 2011, C.J.L.T. 9(2), 2009.

Wilke MS, Heller M, Creagh L, Haynes C, McIntosh L, Poole K, Strynadka NC (2008) The crystal structure of MexR from Pseudomonas aeruginosa in complex with its anti-repressor ArmR. Proc Natl Acad Sci USA 105, 14832-37.

Daigle DM, Cao L, Fraud S, Wilke MS, Pacey A, Klinoski R, Strynadka NC, Dean CR, and Poole K. (2007) A Protein Modulator of Multidrug Efflux Gene Expression in Pseudomonas aeruginosa. J Bacteriol 189, 5441-51.

Wilke MS, Lovering AL, Strynadka NC (2005) Beta-lactam antibiotic resistance: a current structural perspective. Curr Opin Microbiol 8, 525-33.

Wilke MS, Hills TL, Zhang HZ, Chambers HF, Strynadka NC (2004) Crystal structures of the apo and penicillin-acylated forms of the BlaR1 beta-lactam sensor of Staphylococcus aureus. J Biol Chem 279, 47278-87.

Bateman KP, Baker J, Wilke M, Lee J, Leriche T, Seto C, Day S, et al. (2004) Detection of covalent adducts to cytochrome P450 3A4 using liquid chromatography mass spectrometry. Chem Res Toxicol 17, 1356-61.

Previous speaking engagements